972 filings
Page 36 of 49
8-K
ACER
Acer Therapeutics Inc.
17 Dec 09
Opexa Therapeutics, Inc. Announces Closing of $5.1 Million Registered Direct Offering
12:00am
424B5
ACER
Acer Therapeutics Inc.
10 Dec 09
Prospectus supplement for primary offering
12:00am
8-K
ACER
Acer Therapeutics Inc.
10 Dec 09
Opexa Therapeutics, Inc. Announces $5.1 Million Securities Offering
12:00am
8-K
ACER
Acer Therapeutics Inc.
2 Dec 09
Seasoned Clinical Development Expert Joins Opexa to Lead Tovaxin® Development in Multiple Sclerosis
12:00am
EFFECT
ACER
Acer Therapeutics Inc.
1 Dec 09
Notice of effectiveness
12:00am
POS AM
ACER
Acer Therapeutics Inc.
25 Nov 09
Prospectus update (post-effective amendment)
12:00am
CORRESP
ACER
Acer Therapeutics Inc.
25 Nov 09
Correspondence with SEC
12:00am
CORRESP
ACER
Acer Therapeutics Inc.
25 Nov 09
Correspondence with SEC
12:00am
UPLOAD
ACER
Acer Therapeutics Inc.
24 Nov 09
Letter from SEC
12:00am
EFFECT
ACER
Acer Therapeutics Inc.
23 Nov 09
Notice of effectiveness
12:00am
S-3/A
ACER
Acer Therapeutics Inc.
Shelf registration (amended)
18 Nov 09
12:00am
CORRESP
ACER
Acer Therapeutics Inc.
18 Nov 09
Correspondence with SEC
12:00am
CORRESP
ACER
Acer Therapeutics Inc.
18 Nov 09
Correspondence with SEC
12:00am
UPLOAD
ACER
Acer Therapeutics Inc.
17 Nov 09
Letter from SEC
12:00am
POS AM
ACER
Acer Therapeutics Inc.
16 Nov 09
Prospectus update (post-effective amendment)
12:00am
S-3
ACER
Acer Therapeutics Inc.
Shelf registration
13 Nov 09
12:00am
8-K
ACER
Acer Therapeutics Inc.
13 Nov 09
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
ACER
Acer Therapeutics Inc.
5 Nov 09
Other Events
12:00am
8-K
ACER
Acer Therapeutics Inc.
4 Nov 09
Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update
12:00am
10-Q
2009 Q3
ACER
Acer Therapeutics Inc.
Quarterly report
4 Nov 09
12:00am